Status:
UNKNOWN
Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device
Lead Sponsor:
Integrity Applications Ltd.
Conditions:
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Eligibility:
All Genders
10+ years
Phase:
PHASE1
PHASE2
Brief Summary
Diabetes is a leading cause of death in the Western World with medical costs increasing annually. There is no cure for diabetes, and blood glucose monitoring is a key component in diabetes treatment a...
Detailed Description
See Brief summary
Eligibility Criteria
Inclusion
- Type 1or 2 Diabetes
- Anatomically suitable earlobe
Exclusion
- Subjects requiring dialysis
- Any conditions that may hamper good contact between the PEC and the earlobe
- Pregnancy
- Nursing mothers
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00889668
Start Date
May 1 2009
End Date
October 1 2012
Last Update
May 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheba, Israel